Detalhe da pesquisa
1.
Symptom Duration and Resolution With Early Outpatient Treatment of Convalescent Plasma for Coronavirus Disease 2019: A Randomized Trial.
J Infect Dis
; 227(11): 1266-1273, 2023 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36722044
2.
Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trials.
Transfusion
; 63(9): 1639-1648, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37534607
3.
The Effects of Four Doses of Vitamin D Supplements on Falls in Older Adults : A Response-Adaptive, Randomized Clinical Trial.
Ann Intern Med
; 174(2): 145-156, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33284677
4.
Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial.
Alzheimers Dement
; 15(11): 1427-1436, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31587995
5.
Cardiovascular safety signals with dipeptidyl peptidase-4 inhibitors: A disproportionality analysis among high-risk patients.
Pharmacoepidemiol Drug Saf
; 27(6): 660-667, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29655237
6.
Losartan in hospitalized patients with COVID-19 in North America: An individual participant data meta-analysis.
Medicine (Baltimore)
; 102(23): e33904, 2023 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37335665
7.
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis.
medRxiv
; 2022 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35043124
8.
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis.
PLoS One
; 17(9): e0273526, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36173983
9.
Dipeptidyl peptidase-4 inhibitors and cardiovascular events in patients with type 2 diabetes, without cardiovascular or renal disease.
PLoS One
; 15(10): e0240141, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33057387
10.
Maximizing the Post-Approval Safety of Flibanserin: A Role for Regulators, Clinicians, and Patients.
Drug Saf
; 39(5): 375-80, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26798050